Resources
About Us
Meticulous Research®—a leading global market research company, published a research report titled ‘Saudi Arabia Next Generation Sequencing (NGS) Market Size, Share, Forecast, & Trends Analysis by Offering (Sample Preparation (DNA Extraction, Library Preparation), Instruments) Type (SMRT, DNB) Application (Clinical, Research) End User–Forecast to 2031. According to this latest publication from Meticulous Research®, the Saudi Arabia NGS market is expected to reach $50.0 million by 2031, at a CAGR of 10.1% from 2024 to 2031.
The growth of this market is driven by the rising number of cancer cases, increasing pharmaceutical R&D expenditures, and the surge in genome mapping programs are factors driving the growth of the Saudi Arabia NGS market. However, the high costs of NGS systems and consumables, data confidentiality concerns, the availability of alternative technologies, the low chances of identifying positive, actionable biomarkers, and ethical & legal issues related to NGS-based diagnosis restrain the growth of this market
In addition, increasing adoption of NGS tools among hospitals and clinical laboratories and government initiatives supporting large-scale genomic sequencing projects are expected to offer growth opportunities for market players. However, the shortage of skilled professionals, issues related to data storage, handling, interpretation, and confidentiality, and concerns about regulatory standards and standardization in diagnostic testing are some of the challenges impacting the market's growth.
Key Players:
Some of the key players operating in Saudi Arabia NGS market are Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Revvity, Inc. (U.S.), QIAGEN N.V. (Netherlands), Agilent Technologies, Inc. (U.S.), Pacific Biosciences of California, Inc. (U.S.), Danaher Corporation (U.S.), Oxford Nanopore Technologies Plc. (U.K.), Beijing Genomics Institute (BGI) (China), Bio-Rad Laboratories, Inc. (U.S.), and 10x Genomics, Inc. (U.S.).
The Saudi Arabia NGS market is segmented by Offering, Sequencing Type, Application, and End User.
Among the offerings studied in this report, in 2024, the consumables segment is anticipated to dominate the Saudi Arabia NGS market, with a share of 62.6%. The consumables segment is further segmented into sample preparation consumables and sequencing consumables. The sample preparation consumables segment is further categorized into library preparation & target enrichment, DNA extraction & amplification, quality control, and other kits & reagents. In 2024, the library preparation & target enrichment segment is anticipated to dominate the market, with a share of 45.0%. Library preparation solutions provide an end-to-end solution for all library construction steps, such as fragmentation, amplification, adapter ligation, enrichment, and barcoding, contributing to their increased demand in clinical and research settings. Target enrichment enables researchers to enrich specific genes, exons, or genomic regions of interest. It allows the sequencing of regions that are of interest, resulting in reduced time for sequencing and cost savings.
Among the sequencing types studied in this report, in 2024, the targeted genome sequencing segment is anticipated to dominate Saudi Arabia NGS market. Targeted sequencing minimizes the generation of irrelevant genetic variation, which can obscure or complicate clinical interpretation. Additionally, it significantly reduces the cost of sequencing compared to whole genome sequencing (WGS) and whole exome sequencing (WES), particularly when sequencing large populations. Moreover, this technology has facilitated the study of gene-drug associations, aiding in the design of gene-specific drugs with higher precision, thus increasing its adoption.
Among the applications studied in this report, in 2024, the research & other applications segment is anticipated to dominate Saudi Arabia NGS market, with a share of 56.9%. The research & other applications segment is further divided into cancer research, genetic disease research, cell & molecular biology research, microbiology & infectious disease research, agriculture & animal research, and other applications. In 2024, the cancer research segment is anticipated to dominate the market, with a share of 49.4%. The rising cancer incidence, increasing need for novel therapies for cancer treatment, and rising emphasis on personalized cancer therapies are factors contributing to the large market share of this segment. A single NGS-based test can often substitute multiple single-gene tests or small hotspot panels, allowing for the analysis of a wide range of clinically actionable cancer biomarkers in less time, which contributes to its rising adoption.
Among the end users studied in this report, in 2024, the hospitals & diagnostic laboratories segment is anticipated to dominate Saudi Arabia NGS market. In recent years, hospitals and diagnostic laboratories have become major end users of next-generation sequencing technology. The adoption of these technologies has increased in clinical diagnostics, a trend expected to continue as sequencing costs decline, making the technology more accessible to a broader range of healthcare providers. Additionally, Saudi Arabia’s Vision 2030 policy includes initiatives to conduct genetic testing locally and to digitalize diagnostic laboratories. These supportive government policies contribute to the large market share of this segment.
Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=6002
Key Questions Answered in the Report:
Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Kenya IVD Market to be Worth $68.66 Billion by 2032
Read More
Cardiac Biomarkers Market to be Worth $10.08 Billion by 2031
Read More
Cytogenetics Market to be Worth $5.5 Billion by 2031
Read More
Metagenomics Market to be Worth $ 6.71 Billion by 2031
Read More
Dental Lasers Market to be Worth $618.7 million by 2032
Read More
Bakuchiol Serum Market to Reach $4.41 Million by 2032
Read More
Burn Care Market to be Worth $4.32 Billion by 2032
Read More
Africa Medical Devices Market to be Worth $7.14 Billion by 2032
Read More
Middle East Medical Devices Market to be Worth $8.8 Billion by 2032
Read More
Surgical Drills Market to be Worth $1.71 Billion by 2032
Read More
Tissue Engineering Market to reach $7.41 Billion by 2032
Read More
Dental Prosthetics Market to be Worth $ 19.6 Billion by 2032
Read More
Whole Genome Sequencing Market to be Worth $7.17 Billion by 2031
Read More
IVD Assay Development Market to be Worth $8.39 Billion by 2031
Read More
Neurogenomics Market to Reach $4.68 Billion by 2031
Read More
India VNA & PACS Market to Reach $341.6 Million by 2031
Read More
China Microarray Market to Be Worth $910.4 Million by 2031
Read More
China Neurogenomics Market to Reach $562.1 Million by 2031
Read More
ELISA Market to be Worth $32.69 Billion by 2032
Read More
DNA Sequencing Market to be Worth $21.30 Billion by 2031
Read More
Oral Care Market to be Worth $70 Billion by 2032
Read More
Spirometer Market to be Worth $1.80 Billion by 2032
Read More
Viral Vaccines Market to be Worth $64.18 Billion by 2031
Read More
Pet Care Market to be Worth $287.96 Billion by 2032
Read More
Regenerative Medicine Market to be Worth $37.27 Billion by 2031
Read More
Hemostats Market to be Worth $5.32 Billion by 2032
Read More
Bioreactors Market to be Worth $39.96 Billion by 2032
Read More
Protein Assays Market to be Worth $4.36 Billion by 2032
Read More
Veterinary API Market to Reach $15.84 Billion by 2031
Read More
Asia-Pacific NGS Automation Market to be Worth $371 Million by 2032
Read More
Latin America NGS Market to be Worth $765.2 Million by 2032
Read More
Biochemical Reagents Market to be Worth $39.61 Billion by 2032
Read More
Microarray Kits Market to be Worth $2.51 Billion by 2032
Read More
Antibody Production Market to Reach $58.35 Billion by 2032
Read More
Middle East IVD Market to be Worth $2.15 Billion by 2032
Read More
Spatial Genomics Market to be Worth $3.23 Billion by 2031
Read More
Asia-Pacific IVD Market to be Worth $36.02 Billion by 2032
Read More
Europe NGS Market to be Worth $6.40 Billion by 2032
Read More
Lab Automation Market to be Worth $11.31 Billion by 2031
Read More
Bioinformatics Market to Reach $31.71 Billion by 2031
Read More
Europe IVD Market to be Worth $39.77 Billion by 2032
Read More
Sequencing Kits Market to be Worth $25.29 Billion by 2031
Read More
Veterinary API Market to Reach $15.84 Billion by 2032
Read More
U.S. Ambulatory EHR Market to be Worth $3.97 Billion by 2031
Read More
Sample Preparation Market to be Worth $12.77 Billion by 2031
Read More
Surgical Robots Market Worth $25.47 Billion by 2032
Read More
Medical Coatings Market Worth $3.32 Billion by 2032
Read More
Digital Therapeutics Market to be Worth $56.34 Billion by 2031
Read More
Liquid Handling Systems Market Worth $6.99 Billion by 2029
Read More
Electrosurgery Market to be Worth $8.99 Billion by 2031
Read More
Radiation Dose Management Market Worth $749.1 Million by 2029
Read More
Molecular Diagnostics Market Worth $46.69 Billion by 2030
Read More
Newborn Screening Market to be Worth $2.69 Billion by 2031
Read More
Pharmacogenomics Market to be Worth $19.5 Billion by 2031
Read More
Dental Practice Management Software Market Worth $ 3.11 Billion by 2029
Read More
Nepal IVD Market Worth $62.7 Million by 2029
Read More
Pharmaceutical Contract Packaging Market Worth $42.03 Billion by 2029
Read More
Indonesia IVD Market Worth $1.11 Billion by 2029
Read More
Medical Waste Management Market Worth $17.02 billion by 2030
Read More
Empty Capsules Market Worth $4.47 Billion by 2029
Read More
Clear Aligners Market to be worth $18.8 Billion by 2030
Read More
HLA Typing Market Worth $1.9 Billion by 2029
Read More
Real-world Data Market Worth $1.66 billion by 2029
Read More
Track and Trace Solutions Market Worth $27.27 billion by 2029
Read More
Surface Disinfectant Market Worth $9.52 Billion by 2029
Read More
Electronic Lab Notebook Market Worth $787.7 million by 2029
Read More
Rapid Diagnostics Market to be Worth $22.65 Billion By 2031
Read More
Plasma Therapy Market Worth $882.5 Million by 2028
Read More
Peripheral Vascular Devices Market Worth $12.02 Billion by 2028
Read More
Biomaterials Market to Reach 128.7 Billion USD by 2023
Read More
Vaccine Storage Equipment Market Worth $1.83 billion by 2027
Read More
Plasma Fractionation Market Worth $46.9 Billion by 2029
Read More
Home Healthcare Market to be Worth $514.5 Billion by 2030
Read More
Cardiac Pacemaker Devices Market Worth $4.34 Billion by 2028
Read More
European Laboratory Informatics Market Worth $1,084.3 Million By 2024
Read More
Competent Cells Market Worth 2,318.6 Million USD By 2023
Read More
Cancer Immunotherapy Market to be Worth $267.2 Billion by 2030
Read More
Multimodal Imaging Market Worth $1.6 Billion By 2024
Read More
Pulse Lavage Market to be Worth $661.1 Million by 2030
Read More
Medical Cooling Systems Market Worth $2.8 Billion By 2024
Read More
Tissue Diagnostics Market Worth $8.52 Billion by 2029
Read More
Endoscopy Equipment Market Worth $59.8 Billion by 2029
Read More
African Forensic DNA Testing Market Worth $136.3 Million by 2025
Read More
Clinical Trial Supplies Market to be Worth $5.59 Billion by 2031
Read More
Infection Control Market Worth $58.2 Billion by 2027
Read More
Sleep Apnea Devices Market Worth $12.9 billion by 2027
Read More
Medical 3D Printing Market To Reach $983.2 Million By 2020
Read More
Genomics Market to be Worth $70.52 Billion by 2031
Read More
Analytical Standards Market Worth $2.66 Billion By 2027
Read More
Sterilization Equipment Market to be Worth $34.2 Billion by 2035
Read More
Telehealth Market Worth $539.73 Billion by 2029
Read More
Cell Culture Market Worth $48.63 Billion by 2029
Read More
Antimicrobial Coatings Market to be Worth $12.41 Billion by 2031
Read More
Flow Cytometry Market Worth $6.4 Billion by 2027
Read More
Medical Aesthetics Market Worth $29.43 billion by 2029
Read More
Oligonucleotide Synthesis Market Worth $3.9 Billion by 2025
Read More
In Vitro Diagnostics Market to be Worth $116.28 Billion by 2031
Read More
Dental Implants Market Worth $6.52 Billion by 2029
Read More
Active Implantable Devices Market Worth 24.02 Billion USD By 2022
Read More
Ventilators Market to be Worth $13.23 Billion by 2031
Read More
Dialysis Market to be Worth $36.6 Billion by 2031
Read More
Task Trainers Market to Be Worth $2.9 Billion by 2032
Read More
Plasmapheresis Market to be Worth $2.55 Billion by 2030
Read More
Diabetes Care Devices Market Worth $31.9 Billion by 2028
Read More
Clinical Genomics Market Worth 879.0 Million USD By 2023
Read More
IVD Quality Control Market to be Worth $2.28 Billion by 2031
Read More
Laboratory Informatics Market Worth $6.1 Billion by 2030
Read More
Chromatography Data Systems Market to be Worth $1.7 billion by 2030
Read More
Bone Growth Stimulators Market Worth $1.94 Billion by 2030
Read More
Digital Diabetes Market worth $12.03 billion by 2025
Read More
Trocars Market Worth $968.5 Million by 2024
Read More
Healthcare Virtual Assistant Market Worth $1.76 Billion By 2025
Read More
Europe Hospital Beds Market to be Worth $2.09 Billion by 2030
Read More
Immunoassay Market Worth $46.49 Billion by 2028
Read More
Hospital Beds Market to Reach $7.09 Billion by 2031
Read More
Urinalysis Market Worth $2.19 billion by 2027
Read More
Medical Image Management Market Worth $7.22 billion by 2030
Read More
Breast Imaging Market Worth $7.08 Billion by 2027
Read More
VNA & PACS Market to be Worth $6.50 Billion by 2031
Read More